hDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences and Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Ticagrelor was not shown to be noninferior to prasugrel for the reduction of the primary composite endpoint of death, nonfatal myocardial infarction (MI), stroke or major bleeding at one year in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results